Trial intelligence / Profile preview

PRP versus PPP for vasculogenic erectile dysfunction

2019-002057-34Phase 2Active

Sponsor
Fundación de Investigación Biomédica Hospital Puerta de Hierro
Start
Jan 2020
Modality
Adoptive Cell Transfer → Cell Therapies, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Vascular Erectile Dysfunction and erectile dysfunction (ED) comparing PRP arm with PPP control arm (2 arms). Primary endpoint: Change in IIEF-EF score. Started Jan 2020; status: active.

02

Drugs

autologous platelet-rich plasmaplatelet-poor plasma
03

Conditions

Vascular Erectile Dysfunctionerectile dysfunction (ED)

Beyond the preview

Go deeper on 2019-002057-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-002057-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call